Atai Life Sciences N.V.

NASDAQ: ATAI · Real-Time Price · USD
3.88
-0.13 (-3.24%)
At close: Aug 15, 2025, 3:59 PM
3.88
-0.13%
After-hours: Aug 15, 2025, 07:51 PM EDT

Atai Life Sciences Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
17.5M 45.03M 190.61M 362.27M
Short-Term Investments
44.83M 134.22M 82.5M n/a
Long-Term Investments
70.97M 91.66M 6.75M 27.76M
Other Long-Term Assets
850K 14.02M 10.61M 11.18M
Receivables
1.35M 2.26M 5.63M 6.32M
Inventory
n/a n/a -5.63M n/a
Other Current Assets
10.78M 846K 1.75M 756K
Total Current Assets
80.13M 185.59M 287.14M 375.08M
Property-Plant & Equipment
3.87M 2.2M 928K 149K
Goodwill & Intangibles
3.58M 1.77M n/a n/a
Total Long-Term Assets
79.26M 107.89M 18.3M 39.08M
Total Assets
159.39M 293.48M 305.44M 414.17M
Account Payables
2.62M 4.59M 2.4M 6M
Deferred Revenue
n/a n/a -180K n/a
Short-Term Debt
9.36M n/a n/a n/a
Other Current Liabilities
8.53M 1.1M 2.24M 8.24M
Total Current Liabilities
24.95M 20.12M 19.9M 20.93M
Long-Term Debt
14.13M 17.88M 15.12M 743K
Other Long-Term Liabilities
3.02M 10.18M 4.62M 6.53M
Total Long-Term Liabilities
17.88M 29.04M 280.52M 7.27M
Total Liabilities
42.83M 49.16M 300.42M 28.21M
Total Debt
24.71M 19.14M 15.12M 743K
Common Stock
18.79M 18.57M 18.56M 18M
Retained Earnings
-700.21M -550.94M -510.19M -357.8M
Comprehensive Income
-18.47M -19.46M -21.7M -8.34M
Shareholders Equity
116.3M 242.96M 260.74M 376.91M
Total Investments
115.79M 225.89M 89.25M 27.76M